NVO Stock Down as Medicare Selects Semaglutide Drugs for Price Cuts
Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price ...
What they don't tell you about Ozempic: Major study of 2m users exposes the good, bad and ugly
Researchers from the Washington University School of Medicine looked at the health outcomes among more than two million people taking the popular weight-loss medications.
The Financial Express8h
Tirzepatide for weight loss: All you need to know
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
The Financial Express10h
Blockbuster weight loss drug Tirzepatide coming to India soon: Benefits, weight loss potential, and side effects
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...